| scholarly article | Q13442814 |
| P2093 | author name string | David J Taber | |
| Leonard E Egede | |||
| Mukoso N Ozieh | |||
| P2860 | cites work | The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant | Q85759254 |
| Dyslipidemia and its therapeutic challenges in renal transplantation | Q26851294 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Racial disparities in renal transplant outcomes. | Q30304327 | ||
| Calcineurin inhibitors and post-transplant hyperlipidaemias | Q34417640 | ||
| Hyperlipidemia and graft loss | Q34881665 | ||
| Association of race with cumulative exposure to statins in dialysis | Q36160297 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up | Q40485517 | ||
| Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection | Q43628293 | ||
| The effects of lipid-lowering agents on acute renal allograft rejection | Q43690675 | ||
| Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial | Q43796030 | ||
| The effect of pravastatin on acute rejection after kidney transplantation--a pilot study | Q43878216 | ||
| Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients | Q43886135 | ||
| Patient survival after renal transplantation III: the effects of statins | Q44118007 | ||
| Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial | Q44483019 | ||
| Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen | Q45081662 | ||
| Identifying specific causes of kidney allograft loss. | Q45810388 | ||
| How did cause of death contribute to racial differences in life expectancy in the United States in 2010? | Q46720542 | ||
| Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study | Q46816108 | ||
| Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. | Q53394605 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e2283 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes? | |
| P478 | volume | 94 |
Search more.